BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7067730)

  • 1. High-affinity [3H]desipramine binding in the peripheral and central nervous system: a specific site associated with the neuronal uptake of noradrenaline.
    Raisman R; Sette M; Pimoule C; Briley M; Langer SZ
    Eur J Pharmacol; 1982 Mar; 78(3):345-51. PubMed ID: 7067730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of 3H-desipramine to the neuronal noradrenaline carrier of rat phaeochromocytoma cells (PC-12 cells).
    Bönisch H; Harder R
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Dec; 334(4):403-11. PubMed ID: 3821933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [3H]desipramine binding to rat brain tissue: binding to both noradrenaline uptake sites and sites not related to noradrenaline neurons.
    Bäckström IT; Ross SB; Marcusson JO
    J Neurochem; 1989 Apr; 52(4):1099-106. PubMed ID: 2647903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-affinity [3H] DMI binding is associated with neuronal noradrenaline uptake in the periphery and the central nervous system.
    Langer SZ; Raisman R; Briley M
    Eur J Pharmacol; 1981 Jul; 72(4):423-4. PubMed ID: 7274336
    [No Abstract]   [Full Text] [Related]  

  • 5. High-affinity binding of [3H]desipramine to rat brain: a presynaptic marker for noradrenergic uptake sites.
    Rehavi M; Skolnick P; Brownstein MJ; Paul SM
    J Neurochem; 1982 Apr; 38(4):889-95. PubMed ID: 7062040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [3H]desipramine labels with high affinity the neuronal transporter for adrenaline in the frog heart.
    Pimoule C; Schoemaker H; Langer SZ
    Eur J Pharmacol; 1987 Jun; 137(2-3):277-80. PubMed ID: 3497046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of [3H]desipramine binding associated with neuronal norepinephrine uptake sites in rat brain membranes.
    Lee CM; Javitch JA; Snyder SH
    J Neurosci; 1982 Oct; 2(10):1515-25. PubMed ID: 7119871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Norepinephrine neuronal uptake binding sites in rat brain membranes labeled with [3H]desipramine.
    Lee CM; Snyder SH
    Proc Natl Acad Sci U S A; 1981 Aug; 78(8):5250-4. PubMed ID: 6117854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Methoxyflurane and ethanol do not inhibit the neuronal uptake of noradrenaline (uptake 1) at the desipramine binding site].
    Kress HG; Schömig E
    Anaesthesist; 1990 Jul; 39(7):371-4. PubMed ID: 2386305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ageing on the number of neuronal noradrenaline uptake sites in the rat vas deferens.
    Markus RP; Werneck de Avellar MC
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Oct; 346(4):405-9. PubMed ID: 1436126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of neuronal noradrenaline uptake (uptake1) and desipramine binding by N-ethylmaleimide (NEM).
    Schömig E; Michael-Hepp J; Bönisch H
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jun; 337(6):633-6. PubMed ID: 3216896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-affinity uptake of noradrenaline in postsynaptic neurones.
    al-Damluji S; Krsmanovic LZ; Catt KJ
    Br J Pharmacol; 1993 Jun; 109(2):299-307. PubMed ID: 8358534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological modifications of the neurotoxic action of the noradrenaline neurotoxin DSP4 on central noradrenaline neurons.
    Hallman H; Jonsson G
    Eur J Pharmacol; 1984 Aug; 103(3-4):269-78. PubMed ID: 6237924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium-dependence of the potency of inhibitors of the neuronal noradrenaline carrier in the rat vas deferens.
    Zeitner CJ; Graefe KH
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Dec; 334(4):397-402. PubMed ID: 3821932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [3H]mazindol binding associated with neuronal dopamine and norepinephrine uptake sites.
    Javitch JA; Blaustein RO; Snyder SH
    Mol Pharmacol; 1984 Jul; 26(1):35-44. PubMed ID: 6087116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the mechanism of the accumulation of 3H-bretylium in peripheral sympathetic nerves.
    Ross SB; Gosztonyi T
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 288(2-3):283-93. PubMed ID: 1161049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma dihydroxyphenylglycol for estimation of noradrenaline neuronal re-uptake in the sympathetic nervous system in vivo.
    Eisenhofer G; Goldstein DS; Kopin IJ
    Clin Sci (Lond); 1989 Feb; 76(2):171-82. PubMed ID: 2924508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the noradrenaline neurotoxin DSP4 on the postnatal development of central noradrenaline neurons in the rat.
    Jonsson G; Hallman H; Sundström E
    Neuroscience; 1982; 7(11):2895-907. PubMed ID: 7155358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferential location of N-methyl-D-aspartate (NMDA) receptors on postsynaptic membranes and on non-noradrenergic nerve terminals of the rat brain cortex.
    Fink K; Blohm M; Molderings G; Bönisch H; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Jun; 345(6):633-8. PubMed ID: 1386145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Choline+: a substrate of the neuronal noradrenaline carrier in the rat vas deferens.
    Ungell AL; Bönisch H; Graefe KH
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Nov; 334(3):223-7. PubMed ID: 3027585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.